RxDoctor Payments DataLook up a doctor →

Charles Kelly, MD

Neurology · Mt Pleasant, SCNPI 1760402473

Payments from drug & device makers

$61,610in general payments, 2019–2025

Across 1,403 payments — averaging $43.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$33K
  • Harmony Biosciences LLC$9K
  • AbbVie$2K
  • EMD Serono, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • UCB, Inc.$1K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis71$32,599
Harmony Biosciences LLC84$8,780
AbbVie(2 entities)178$2,339
EMD Serono, Inc.105$1,687
Teva Pharmaceuticals USA, Inc.111$1,263
UCB, Inc.63$1,238
Jazz Pharmaceuticals Inc.71$1,115
Pfizer39$748
Neurocrine Biosciences, Inc.45$721
Biogen38$692
Sanofi34$687
Supernus Pharmaceuticals, Inc.44$659
Amgen(2 entities)44$608
SK Life Science, Inc.29$548
Lilly USA, LLC33$521
Genentech USA, Inc.33$520
AstraZeneca(2 entities)17$470
Bristol Myers Squibb42$410
Argenx US, Inc.19$373
Biohaven Pharmaceutical Holding Company Ltd.20$366
Eisai Inc.16$300
Mallinckrodt Hospital Products Inc.15$285
Lundbeck LLC13$284
Johnson & Johnson(2 entities)14$276
Impel Pharmaceuticals Inc.34$267
Amneal Pharmaceuticals LLC14$253
Acorda Therapeutics, Inc10$229
Avanir Pharmaceuticals, Inc.12$222
MDD US Operations, LLC9$220
Otsuka America Pharmaceutical, Inc.11$218
Takeda Pharmaceuticals U.S.A., Inc.10$213
Axsome Therapeutics, Inc.9$175
Acadia Pharmaceuticals Inc3$174
Upsher-smith Laboratories LLC7$156
Octapharma USA, Inc.3$147
Banner Life Sciences, LLC8$132
TG Therapeutics, Inc.6$122
GE HealthCare7$118
Bayer7$99
E.r. Squibb & Sons, L.L.C.4$86
Idorsia Pharmaceuticals US Inc5$85
Kyowa Kirin, Inc.6$80
Grifols USA, LLC3$78
Biohaven Pharmaceuticals, Inc.4$77
Assertio Therapeutics, Inc.4$70
Sunovion Pharmaceuticals Inc.5$64
Sumitomo Pharma America, Inc.4$63
Averitas Pharma Inc.2$58
Tersera Therapeutics LLC2$58
Avadel CNS Pharmaceuticals, LLC3$57
Vanda Pharmaceuticals Inc.2$49
Merz Pharmaceuticals, LLC2$48
Adamas Pharmaceuticals, Inc.3$46
Alnylam Pharmaceuticals Inc.2$39
Merz North America, Inc.1$34
Mallinckrodt Enterprises LLC2$33
CSL Behring2$29
Boston Scientific1$28
Amylyx Pharmaceuticals, Inc.1$28
Medtronic(2 entities)2$25

How this compares

$61,610 in reported general payments places this provider in the 85th percentile of 270 neurology providers in South Carolina.

See all neurology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$394,821
Medicare patients
861
Services billed
18,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Mt Pleasant

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →